Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2010-01-18
2010-12-21
Padmanabhan, Sreeni (Department: 1627)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C514S657000
Reexamination Certificate
active
07855233
ABSTRACT:
The subject invention provides rasagiline citrate, its compositions and processes for the manufacture thereof.
REFERENCES:
patent: 5387612 (1995-02-01), Youdim et al.
patent: 5453446 (1995-09-01), Youdim et al.
patent: 5457133 (1995-10-01), Youdim et al.
patent: 5486541 (1996-01-01), Sterling et al.
patent: 5519061 (1996-05-01), Youdim et al.
patent: 5532415 (1996-07-01), Youdim et al.
patent: 5576353 (1996-11-01), Youdim et al.
patent: 5599991 (1997-02-01), Youdim et al.
patent: 5663415 (1997-09-01), Chopdekar et al.
patent: 5668181 (1997-09-01), Youdim et al.
patent: 5744500 (1998-04-01), Youdim et al.
patent: 5786390 (1998-07-01), Youdim et al.
patent: 5891923 (1999-04-01), Youdim et al.
patent: 6126968 (2000-10-01), Peskin et al.
patent: 6277886 (2001-08-01), Levy et al.
patent: 6316504 (2001-11-01), Youdim et al.
patent: 6462222 (2002-10-01), Chorev et al.
patent: 6548706 (2003-04-01), Malik et al.
patent: 6630514 (2003-10-01), Youdim et al.
patent: 6956060 (2005-10-01), Youdim et al.
patent: 7396860 (2008-07-01), Blaugrund et al.
patent: 7491847 (2009-02-01), Frenkel
patent: 7547806 (2009-06-01), Frenkel et al.
patent: 7572834 (2009-08-01), Sterling et al.
patent: 7598420 (2009-10-01), Sterling et al.
patent: 7619117 (2009-11-01), Lidor-Hadas et al.
patent: 7750051 (2010-07-01), Frenkel et al.
patent: 7815942 (2010-10-01), Peskin
patent: 2003/0180332 (2003-09-01), Rimpler et al.
patent: 2006/0018957 (2006-01-01), Lerner et al.
patent: 2006/0094783 (2006-05-01), Youdim
patent: 2006/0188581 (2006-08-01), Peskin
patent: 2007/0078172 (2007-04-01), McElroy et al.
patent: 2007/0093495 (2007-04-01), Ruggero
patent: 2007/0100001 (2007-05-01), Youdim et al.
patent: 2007/0112217 (2007-05-01), Frenkel
patent: 2007/0232700 (2007-10-01), Blaugrund et al.
patent: 2008/0161408 (2008-07-01), Frenkel et al.
patent: 2008/0208287 (2008-08-01), Palermo et al.
patent: 2008/0261894 (2008-10-01), Kreitman et al.
patent: 2009/0054504 (2009-02-01), Bozik et al.
patent: 2009/0062400 (2009-03-01), Oron et al.
patent: 2009/0076160 (2009-03-01), Lendvai et al.
patent: 2009/0111892 (2009-04-01), Patashnick et al.
patent: 2009/0136549 (2009-05-01), Lin et al.
patent: 2009/0181086 (2009-07-01), Safadi et al.
patent: 2009/0220611 (2009-09-01), Dargelas et al.
patent: 2009/0247537 (2009-10-01), Overfield
patent: 2009/0312436 (2009-12-01), Levy et al.
patent: 2009/0318564 (2009-12-01), Frenkel et al.
patent: 2010/0008983 (2010-01-01), Safadi et al.
patent: 2010/0010095 (2010-01-01), Frenkel
patent: 2010/0010098 (2010-01-01), Elffrink
patent: 2010/0189787 (2010-07-01), Safadi et al.
patent: 2010/0189788 (2010-07-01), Safadi et al.
patent: 2010/0189790 (2010-07-01), Safadi et al.
patent: 2010/0189791 (2010-07-01), Safadi et al.
patent: WO 95/11016 (1995-04-01), None
patent: WO 98/40102 (1998-09-01), None
patent: WO 2004/089353 (2004-10-01), None
patent: WO 2006/014973 (2006-02-01), None
patent: WO 2006/057912 (2006-06-01), None
patent: WO 2008/076315 (2006-06-01), None
patent: WO 2007/10299 (2007-01-01), None
patent: WO 2007/060491 (2007-05-01), None
patent: WO 2008/010786 (2008-01-01), None
patent: WO 2008/019871 (2008-02-01), None
patent: WO 2008/076348 (2008-06-01), None
patent: WO 2008/131961 (2008-11-01), None
patent: WO 2008/139934 (2008-11-01), None
patent: WO 2009/122301 (2009-10-01), None
patent: WO 2009/152777 (2009-12-01), None
patent: PCT/EP2010/059723 (2010-07-01), None
Perrin et al. (Purification of Laboratory Chemicals Second Edition).
Chen et al. (Clinical Pharmacology of Rasagiline: A Novel, Second-Generation Propargylamine for the Treatment of Parkinson Disease).
U.S. Appl. No. 12/456,642, filed Jun. 19, 2009 (Anton Frenkel) (specification and pending claim set is attached).
U.S. Appl. No. 12/456,643, filed Jun. 19, 2009 (Frenkel et al.) (specification and pending claim set is attached).
U.S. Appl. No. 12/455,969, filed Jun. 10, 2009 (Safadi et al..) (specification and pending claim set is attached).
U.S. Appl. No. 12/456,031, filed Jun. 9, 2009 (Safadi et al.) (specification and pending claim set is attached).
U.S. Appl. No. 12/456,029, filed Jun. 9, 2009 (Safadi et al.) (specification and pending claim set is attached).
U.S. Appl. No. 12/455,976, filed Jun. 9, 2009 (Safadi et al.) (specification and pending claim set is attached).
U.S. Appl. No. 12/456,001, filed Jun. 9, 2009 (Safadi et al.) (specification and pending claim set is attached).
Azilect®, Physician's Desk Reference (2009), 63th Edition, Thomson Healthcare.
Snodin D., (2006) “Residues of genotoxic alkyl mesylates in mesylate salt drug substances . . .” Regulatory Toxicology and Pharmacology, vol. 45, pp. 79-90.
U.S. Appl. No. 12/283,107, filed Sep. 8, 2008 (Sterling et al.) (specification and pending claim set is attached).
U.S. Appl. No. 12/223,794, filed Aug. 7, 2008 (Poewe) (specification and pending claim set is attached).
U.S. Appl. No. 12/456,166, filed Jun. 12, 2009 (Levy et al.) (specification and pending claim set is attached).
Mar. 16, 2010 International Search Report and the Written Opinion of the International Searching Authority for International Application No. PCT/US10/00174.
Jul. 28, 2000 Amendment filed in the U.S. Appl. No. 09/043,475.
May 2, 2000 Notice of Allowance issued in the U.S. Appl. No. 09/043,475.
Feb. 10, 2000 Amendment filed in the U.S. Appl. No. 09/043,475.
Nov. 10, 1999 Notice of Allowance issued in the U.S. Appl. No. 09/043,475.
Sep. 16, 1999 Amendment filed in the U.S. Appl. No. 09/043,475.
Jun. 16, 1999 Office Action issued in the U.S. Appl. No. 09/043,475.
Jul. 26, 2010 Extended European Search Report issued in European Patent Application No. 10151462.8.
“A Controlled Trial of Rasagiline . . . . The Tempo Study”, Archives of Neurology, American Medical Association, Chicago, IL, US, vol. 59, Dec. 1, 2002, pp. 1937-1943.
Gould P. L, “Salt Selection for Basic Drugs”, International Journal of Pharmaceutics, Elsevier BV, NL Lnkd-DOI:10.1016/0378-5173(86)90055-4, vol. 33, No. 1/03, January.
Feb. 12, 2009 Notice of Allowance issued in U.S. Appl. No. 12/002,076.
Jan. 12, 2009 Amendment filed in U.S. Appl. No. 12/007,076.
Jul. 11, 2008 Office Action issued in U.S. Appl. No. 12/002,076.
Sep. 30, 2010 Extended European Search Report issued in European Patent Application No. 10166534.7.
Frenkel Anton
Koltai Tamas
Safadi Muhammad
Cooper & Dunham LLP
Padmanabhan Sreeni
Soroush Layla
Teva Pharmaceutical Industries Ltd.
White John P.
LandOfFree
Citrate salt of Rasagiline does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Citrate salt of Rasagiline, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Citrate salt of Rasagiline will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4168701